Xtane

Xtane by Natco Pharma is a pharmaceutical-grade, high-potency Steroidal Aromatase Inhibitor (AI) containing pure Exemestane at a concentration of 25mg per tablet in a container/strip of 30 tablets. Manufactured by Natco Pharma—a world-renowned, WHO-GMP certified pharmaceutical leader—Xtane is produced under rigorous global quality control standards, ensuring exact chemical purity, uniform dosage, and high oral bioavailability.

Exemestane is classified as a Type-I irreversible “suicidal” aromatase inactivator. Originally developed in oncology for the treatment of hormone-receptor-positive breast cancer, Xtane is widely utilized in athletic, bodybuilding, and endocrinology contexts to permanently neutralize aromatase enzymes, eliminating systemic estrogen conversion at the root without the risk of an estrogen “rebound” upon discontinuation.

Key Benefits & Applications

• Permanent Enzymatic Inactivation: Irreversibly binds to and permanently destroys aromatase enzymes, guaranteeing zero estrogen rebound after stopping administration.

• Elimination of Water Retention & Bloat: Strips away subcutaneous fluid accumulation and bloating caused by high circulating estradiol, helping restore a tight, hard, and defined physical look.

• Gynecomastia Prevention & Management: Stops the proliferation of breast tissue caused by heavy conversion of aromatizable androgens into estradiol.

• IGF-1 Preservation & Enhancement: Unlike non-steroidal AIs (such as Anastrozole or Letrozole) which can depress insulin-like growth factor 1, Exemestane has been demonstrated in clinical settings to slightly increase circulating IGF-1 levels.

• Endogenous Testosterone Support: Lowering central estrogen feedback stimulates the pituitary gland to release LH and FSH, making Xtane a valuable inclusion in specific PCT or recovery protocols.